A randomized, placebo-controlled, trial to assess safety, tolerability, and immunogenicity of influenza virus vaccine, trivalent, types A & B, live cold-adapted (FluMist) and measles, mumps, rubella, (MMRII) and varicella (VARIVAXO) vaccines administered concurrently to healthy children (AV018)

Trial Profile

A randomized, placebo-controlled, trial to assess safety, tolerability, and immunogenicity of influenza virus vaccine, trivalent, types A & B, live cold-adapted (FluMist) and measles, mumps, rubella, (MMRII) and varicella (VARIVAXO) vaccines administered concurrently to healthy children (AV018)

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2008

At a glance

  • Drugs Influenza virus vaccine live; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
  • Indications Chickenpox; Influenza A virus infections; Influenza virus infections; Measles; Mumps; Rubella
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Feb 2008 Status changed from in progress to completed.
    • 05 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top